Drug intelligence / Profile preview

oxyresveratrol

Development stage
Phase 3
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

**Oxyresveratrol** is a naturally occurring hydroxystilbene, structurally related to resveratrol, and found in several plant species including Morus alba (white mulberry). It exhibits diverse biological and pharmacological activities, most notably as a **potent inhibitor of tyrosinase**—an enzyme involved in melanin production—making it of interest in cosmetic and dermatological applications for skin lighting and depigmentation[1][2][3]. Oxyresveratrol also shows significant **antioxidant**, **anti-inflammatory**, and **neuroprotective** properties, as well as potential hepatoprotective and anti-allergic actions[1][2]. Mechanistically, it reversibly inhibits tyrosinase through a mixed-type or competitive inhibition, depending on the substrate, and displays higher antioxidant activity than resveratrol in several assays[1]. Neuroprotective effects involve reduction of apoptotic cell death and suppression of pro-inflammatory mediators[2]. Oxyresveratrol is under investigation in a range of indications including inflammatory and neurodegenerative diseases, but is not currently an approved pharmaceutical for any indication.

Other names
oxyresveratrolresveratrol oxidehydroxyresveratrol4-[(E)-2-(3,5-dihydroxystyryl)phenol]OXYLRESVERATROL
02

Targets

ALOX12 (Arachidonate 12-lipoxygenase, 12S type)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)NOS2 (Nitric Oxide Synthase 2)PDE2 (Phosphodiesterase 2)TYR (Tyrosinase)

Beyond the preview

Go deeper on oxyresveratrol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oxyresveratrol.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call